2019/06/28 08:02:19 | |
---|---|
Price | |
9.12 EUR | |
Difference | 1.33% (0.12) |
ISIN | CH1260041939 |
Symbol | OBSN |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 9.12 EUR |
High | 9.12 EUR |
Low | 9.12 EUR |
Close (prev. day) | 9.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2024/05/29 |
![]() |
Global Equity Ratings |
![]() |
2024/04/26 |
![]() |
Global Equity Ratings |
![]() |
2019/06/28 08:02:19 | |
---|---|
Price | |
9.12 EUR | |
Difference | 1.33% (0.12) |
ISIN | CH1260041939 |
Symbol | OBSN |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 9.12 EUR |
High | 9.12 EUR |
Low | 9.12 EUR |
Close (prev. day) | 9.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -5.87% | - | - |
Perf (abs.) | -0.57 | - | - |
Beta | -164.32 | -77.01 | -11.11 |
Volatility | 63.46 | 80.30 | 80.30 |
Ø price 5 days | Ø volume 5 days (pcs.) | 9.25 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 10.04 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 10.69 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | - EUR (6) |
YTD High | date | 13.01 EUR (2019/01/22) |
YTD Low | date | 8.62 EUR (2019/06/14) |
52 Weeks High | date | 16.93 EUR (2018/09/28) |
52 Weeks Low | date | 8.62 EUR (2019/06/14) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
SIX Swiss Exchange | 2024/05/03 | 17:33 | 0.0012 CHF | 0.01 | 51 |
Frankfurt | 2019/06/28 | 15:43 | 9.22 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/07/16 | 21:52 | 0.0000 USD | 0.00 | 3 |
Berlin | 2019/06/28 | 08:02 | 9.12 EUR | 0.00 | 1 |
OBSEVA SA |
- - |
Chemin des Aulx, 12, Plan-les-Ouates - 1228 Genf |
Telefon: +41-22-552-38-40 |
Fax: + |
E-mail: contact@obseva.ch |
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland. |
Fabien de Ladonchamps | Chairman of Managing Board |
Luigi Marro | Member of the administrative board |
Ernest Loumaye | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer